Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
MILES' GLUCOBAY FOR DIABETES NOT RECOMMENDED FOR APPROVAL: CMTE. CITES LACK OF CLINICAL EFFICACY AND LONG-TERM USE DATA AS WELL AS LIVER TOXICITY POTENTIAL
Jul 29 1991
•
By
The Pink Sheet
More from Archive
More from Pink Sheet